Literature DB >> 7689173

HIV and multidrug resistance.

E A Emini, D J Graham, L Gotlib, J H Condra, V W Byrnes, W A Schleif.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7689173     DOI： 10.1038/364679b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.

Authors:  Robert W Shafer; Rami Kantor; Matthew J Gonzales
Journal:  AIDS Rev       Date:  2000       Impact factor: 2.500

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  Sources of error in the retracted scientific literature.

Authors:  Arturo Casadevall; R Grant Steen; Ferric C Fang
Journal:  FASEB J       Date:  2014-06-13       Impact factor: 5.191

Review 4.  Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Authors:  Robert W Shafer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

5.  Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.

Authors:  Horrick Sharma; Tino W Sanchez; Nouri Neamati; Mervi Detorio; Raymond F Schinazi; Xiaolin Cheng; John K Buolamwini
Journal:  Bioorg Med Chem Lett       Date:  2013-09-11       Impact factor: 2.823

Review 6.  Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.

Authors:  B D Alexander; J R Perfect
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

7.  Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

Authors:  D D Richman; D Havlir; J Corbeil; D Looney; C Ignacio; S A Spector; J Sullivan; S Cheeseman; K Barringer; D Pauletti
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

Authors:  A K Iversen; R W Shafer; K Wehrly; M A Winters; J I Mullins; B Chesebro; T C Merigan
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

Authors:  T Shirasaka; M F Kavlick; T Ueno; W Y Gao; E Kojima; M L Alcaide; S Chokekijchai; B M Roy; E Arnold; R Yarchoan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors.

Authors:  V W Byrnes; E A Emini; W A Schleif; J H Condra; C L Schneider; W J Long; J A Wolfgang; D J Graham; L Gotlib; A J Schlabach
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.